Structures of Ceftazidime and Its Transition-State Analogue in Complex with AmpC β-Lactamase: Implications for Resistance Mutations and Inhibitor Design,-Reference-Cited by-同舟云学术

Structures of Ceftazidime and Its Transition-State Analogue in Complex with AmpC β-Lactamase: Implications for Resistance Mutations and Inhibitor Design,

Published:2001-07-10 Issue:31 Volume:40 Page:9207-9214
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Powers Rachel A.¹,Caselli Emilia¹,Focia Pamela J.¹,Prati Fabio¹,Shoichet Brian K.¹

Affiliation:

1. Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, 303 East Chicago Avenue, Chicago, Illinois 60611, and Dipartimento di Chimica, Università degli Studi di Modena, Via Campi 183, Modena, Italy

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi0109358

Reference31 articles.

1. TEM β-Lactamase Mutants Hydrolysing Third-generation Cephalosporins

2. Structural Basis of Extended Spectrum TEM β-Lactamases

3. Evidence for Structural Elasticity of Class A β-Lactamases in the Course of Catalytic Turnover of the Novel Cephalosporin Cefepime

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance;Biophysical Chemistry;2024-06

2. Structural insights into the molecular mechanism of high-level ceftazidime–avibactam resistance conferred by CMY-185;mBio;2024-02-14

3. Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase;Antimicrobial Agents and Chemotherapy;2023-11-15

4. ACT-107, a novel variant of AmpC β-lactamase from Enterobacter huaxiensis isolated from Neotropical leaf frog (Phyllomedusa distincta) inhabiting the Brazilian Atlantic Forest;Journal of Global Antimicrobial Resistance;2023-06

5. Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa;Antimicrobial Agents and Chemotherapy;2023-02-16